Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sound waves and supercharged immune cells take on deadly brain tumors

NCT ID NCT07343986

First seen Jan 18, 2026 · Last updated May 01, 2026 · Updated 11 times

Summary

This early-stage study tests a new treatment for a type of aggressive brain cancer called glioblastoma. The approach uses the patient's own immune cells, trained to attack the tumor, combined with low-intensity focused ultrasound to temporarily open the blood-brain barrier so the cells can reach the brain. The study aims to see if this combination is safe and feasible in 12 adults with newly diagnosed, treatment-resistant glioblastoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Virginia

    RECRUITING

    Charlottesville, Virginia, 22903, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.